# VK2735 VENTURE trial: weight loss at 13 weeks | PepVault

Source: https://pepvault.app/research/vk2735-venture-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [VK2735](https://pepvault.app/research#vk2735)

Randomized trial · people

# VK2735: up to 14.7% weight loss at 13 weeks in VENTURE

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Every dose of VK2735 in this phase 2 trial led to weight loss over 13 weeks, and gut-related side effects were the main issue, reported less often as treatment went on.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2026
- **Journal:** Obesity (Silver Spring)

## What they tested

The team wanted to find which weekly doses of VK2735 lead to weight loss over 13 weeks.

## How the study was done

A phase 2, randomized, double-blind, placebo-controlled trial that tested several doses of VK2735, given as a weekly shot under the skin, against placebo (a dummy shot) for 13 weeks. It enrolled adults with obesity, or overweight plus at least 1 weight-related health problem, and did not include people with diabetes.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking VK2735? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Average weight loss on VK2735 ranged from 9.2 kg (9.1%) in the 2.5 mg arm to 14.6 kg (14.7%) in the 15 mg arm, while the placebo group lost 1.8 kg (1.7%). Among people on VK2735, 93% (130/140) lost at least 5% of their starting weight, compared with 12% (4/34) on placebo. The most common side effects involved the stomach and gut, and people reported them less often once the dose had been stepped up and held steady.

## What it doesn’t show

At 13 weeks, this trial is short and does not show what happens with longer use or after stopping. People with diabetes were not included, and the placebo group was small.

## The paper

Bays et al. Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study. Obesity (Silver Spring). 2026.

- [PubMed (PMID 41508550)](https://pubmed.ncbi.nlm.nih.gov/41508550/)
- [The paper (DOI 10.1002/oby.70106)](https://doi.org/10.1002/oby.70106)
- [ClinicalTrials.gov (NCT06068946)](https://clinicaltrials.gov/study/NCT06068946)

## The compound

- [VK2735: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/vk2735)
- [VK2735 dose guide](https://pepvault.app/lab/dosage/vk2735)

## With this study

### VK2735

- [VK2735: the full reference](https://pepvault.app/peptides/vk2735)
- [VK2735 dose guide](https://pepvault.app/lab/dosage/vk2735)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/vk2735-10mg)

### Studies

- [The study on the research page](https://pepvault.app/research#vk2735)

### Compared with

- [Tirzepatide vs VK2735](https://pepvault.app/peptides/compare/tirzepatide-vs-vk2735)
- [Retatrutide vs VK2735](https://pepvault.app/peptides/compare/retatrutide-vs-vk2735)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking VK2735? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking VK2735? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### VK2735

- [VK2735: the full reference](https://pepvault.app/peptides/vk2735)
- [VK2735 dose guide](https://pepvault.app/lab/dosage/vk2735)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/vk2735-10mg)

### Studies

- [The study on the research page](https://pepvault.app/research#vk2735)

### Compared with

- [Tirzepatide vs VK2735](https://pepvault.app/peptides/compare/tirzepatide-vs-vk2735)
- [Retatrutide vs VK2735](https://pepvault.app/peptides/compare/retatrutide-vs-vk2735)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking VK2735? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on VK2735](https://pepvault.app/research#vk2735)

## The library

- [VK2735](https://pepvault.app/peptides/vk2735)
- [VK2735 dose guide](https://pepvault.app/lab/dosage/vk2735)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
